Showing results (91-100 of 298) with videos related to

Sort By:
Pageof 30
The Journal of Pediatrics|October 1, 1974
Combined immunodeficiency and reticuloendotheliosis with eosinophiliaH D Ochs, S D Davis, E Mickelson, et al.
JPGN Reports|May 18, 2023
Trichobezoar: A Rare Cause of Protein-losing EnteropathyAnam Bashir, Andrea Gosalvez Tejada, Keith T Oldham, et al.
Plos Computational Biology|June 27, 2024
Prioritizing drug targets by perturbing biological network response functionsMatthew C Perrone, Michael G Lerner, Matthew Dunworth, et al.
American Journal of Surgery|October 14, 2003
Who are we and what do we think?Peter D Beitsch, Arthur G Lerner, Allison L Laidley, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
DNA cleavage activities of Staphylococcus aureus gyrase and topoisomerase IV stimulated by quinolones and 2-pyridonesA Y Saiki, L L Shen, C M Chen, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|August 21, 2001
Impact of total body water errors on Kt/V estimates in children on peritoneal dialysisB Morgenstern, K S Nair, G Lerner, et al.
Transplantation|September 1, 1977
Marrow grafts between DLA-identical and homozygous unrelated dogs: evidence for an additional locus involved in graft-versus-host diseaseR Storb, P L Weiden, T C Graham, et al.
The Israel Journal of Psychiatry and Related Sciences|September 14, 2002
Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approachArturo G Lerner, Marc Gelkopf, Irena Skladman, et al.
International Clinical Psychopharmacology|June 3, 2000
LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot studyA G Lerner, M Gelkopf, I Oyffe, et al.
Frontiers in Public Health|August 27, 2014
Exploring Substance Use and HIV Treatment Factors Associated with Neurocognitive Impairment among People Living with HIV/AIDSJennifer M Attonito, Jessy G Dévieux, Brenda D G Lerner, et al.
Pageof 30